Revenue of Sinopharm 2011-2022, by category
In 2022, the Chinese pharmaceutical giant Sinopharm group reported annual revenue of over 552 billion yuan. The vast majority of the company's revenue was generated by the sale of products, including medicine and medical equipment. The widespread adaption of COVID-19 vaccines developed and produced by two subsidiaries of the group also contributed to the growth of the revenue figures.